{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:25:53Z","timestamp":1787498753529,"version":"build-2736575974"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.yebeh.2020.107296","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T23:19:27Z","timestamp":1596669567000},"page":"107296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Metabolic syndrome and obstructive sleep apnea syndrome among patients with epilepsy on monotherapy"],"prefix":"10.1016","volume":"111","author":[{"given":"Elif","family":"S\u00f6ylemez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oya","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezin Alpayd\u0131n","family":"Baslo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep Ezgi","family":"Bal\u00e7\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Atakl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2020.107296_bb0005","doi-asserted-by":"crossref","first-page":"106390","DOI":"10.1016\/j.yebeh.2019.05.052","article-title":"Physical activity and sedentary levels among people living with epilepsy: a systematic review and meta-analysis","volume":"99","author":"Vancampfort","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107296_bb0010","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.yebeh.2010.12.012","article-title":"Nonalcoholic fatty liver disease in adolescents receiving valproic acid","volume":"20","author":"Verrotti","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107296_bb0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.seizure.2016.03.002","article-title":"Metabolic syndrome in young adults with epilepsy","volume":"37","author":"Nair","year":"2016","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.yebeh.2020.107296_bb0020","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1528-1167.2007.01052.x","article-title":"Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy","volume":"48","author":"Kim","year":"2007","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107296_bb0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5001\/omj.2015.06","article-title":"Frequency of obstructive sleep apnea syndrome among patients with epilepsy attending a tertiary neurology clinic","volume":"30","author":"Al-Abri","year":"2015","journal-title":"Oman Med J"},{"issue":"Suppl. 2","key":"10.1016\/j.yebeh.2020.107296_bb0030","first-page":"S175","article-title":"Excessive daytime sleepiness and obstructive sleep apnea in Thai epileptic patients","volume":"97","author":"Ruangkana","year":"2014","journal-title":"J Med Assoc Thai"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107296_bb0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.eplepsyres.2013.02.015","article-title":"Routine polysomnography in an epilepsy monitoring unit","volume":"105","author":"Phillips","year":"2013","journal-title":"Epilepsy Res"},{"issue":"5","key":"10.1016\/j.yebeh.2020.107296_bb0040","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/14737175.2017.1262259","article-title":"Diagnosis and treatment of epilepsy and sleep apnea comorbidity","volume":"17","author":"Liu","year":"2017","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107296_bb0045","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.yebeh.2020.107296_bb0050","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1528-1157.1996.tb01035.x","article-title":"Epilepsy in the tropics: I. Epidemiology, socioeconomic risk factors, and etiology","volume":"37","author":"de Bittencourt (Chairman)","year":"1996","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.yebeh.2020.107296_bb0055","doi-asserted-by":"crossref","first-page":"a022426","DOI":"10.1101\/cshperspect.a022426","article-title":"Seizures and epilepsy: an overview for neuroscientists","volume":"5","author":"Stafstrom","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107296_bb0060","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies","volume":"88","author":"Fiest","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107296_bb0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1468-1331.2004.00992.x","article-title":"The epidemiology of epilepsy in Europe \u2014 a systematic review","volume":"12","author":"Forsgren","year":"2005","journal-title":"Eur J Neurol"},{"issue":"10","key":"10.1016\/j.yebeh.2020.107296_bb0070","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jfma.2017.06.001","article-title":"Classifications of seizures and epilepsyes, where are we? \u2014 a brief historical review and update","volume":"116","author":"Chang","year":"2017","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"10.1016\/j.yebeh.2020.107296_bb0075","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.14-0970","article-title":"International classification of sleep disorders-third edition: highlights and modifications","volume":"146","author":"Sateia","year":"2014","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107296_bb0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1059-1311(96)80066-5","article-title":"Improvement of epileptic seizure control with treatment of obstructive sleep apnoea","volume":"5","author":"Vaughn","year":"1996","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.yebeh.2020.107296_bb0085","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1212\/WNL.48.5.1389","article-title":"Usefulness of polysomnography in epilepsy patients","volume":"48","author":"Malow","year":"1997","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.yebeh.2020.107296_bb0090","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.sleep.2003.06.004","article-title":"Identification and treatment of obstructive sleep apnea in adults and children with epilepsy: a prospective pilot study","volume":"4","author":"Malow","year":"2003","journal-title":"Sleep Med"},{"issue":"Suppl. 2","key":"10.1016\/j.yebeh.2020.107296_bb0095","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.yebeh.2003.07.005","article-title":"Epilepsy and sleep disturbance","volume":"4","author":"Bazil","year":"2003","journal-title":"Epilepsy Behav"},{"issue":"8","key":"10.1016\/j.yebeh.2020.107296_bb0100","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1249\/01.MSS.0000079076.74931.9A","article-title":"Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome","volume":"35","author":"Lakka","year":"2003","journal-title":"Med Sci Sports Exerc"},{"issue":"10","key":"10.1016\/j.yebeh.2020.107296_bb0105","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1249\/01.MSS.0000089337.73244.9B","article-title":"Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study","volume":"35","author":"Katzmarzyk","year":"2003","journal-title":"Med Sci Sports Exerc"},{"issue":"9","key":"10.1016\/j.yebeh.2020.107296_bb0110","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ehj.2004.02.021","article-title":"Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome","volume":"25","author":"Coughlin","year":"2004","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.yebeh.2020.107296_bb0115","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.yebeh.2020.107296_bb0120","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.sleep.2014.03.012","article-title":"Evaluation of five different questionnaires for assessing sleep apnea syndrome in a sleep clinic","volume":"15","author":"Pataka","year":"2014","journal-title":"Sleep Med"},{"issue":"7","key":"10.1016\/j.yebeh.2020.107296_bb0125","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1528-1167.2007.01052.x","article-title":"Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy","volume":"48","author":"Kim","year":"2007","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.yebeh.2020.107296_bb0130","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1528-1157.2001.10401.x","article-title":"A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE task force on classification and terminology","volume":"42","author":"Engel","year":"2001","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.yebeh.2020.107296_bb0135","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2013.05.064","article-title":"Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999\u20132010","volume":"62","author":"Beltr\u00e1n-S\u00e1nchez","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.yebeh.2020.107296_bb0140","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.seizure.2012.06.001","article-title":"Metabolic syndrome among Chinese obese patients with epilepsy on sodium valproate","volume":"21","author":"Fang","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107296_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.seizure.2016.03.008","article-title":"Metabolic syndrome and anticonvulsants: a comparative study of valproic acid and carbamazepine","volume":"38","author":"Rakitin","year":"2016","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107296_bb0150","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.seizure.2006.12.009","article-title":"Valproate, weight gain and carbohydrate craving: a gender study","volume":"16","author":"El-Khatib","year":"2007","journal-title":"Seizure"},{"issue":"2\u20133","key":"10.1016\/j.yebeh.2020.107296_bb0155","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eplepsyres.2008.03.017","article-title":"Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children","volume":"80","author":"Rauchenzauner","year":"2008","journal-title":"Epilepsy Res"},{"issue":"10","key":"10.1016\/j.yebeh.2020.107296_bb0160","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1111\/epi.12338","article-title":"Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy","volume":"54","author":"Kim","year":"2013","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107296_bb0165","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1528-1167.2009.02206.x","article-title":"The metabolic syndrome in overweight epileptic patients treated with valproic acid","volume":"51","author":"Verrotti","year":"2010","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.yebeh.2020.107296_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103856","article-title":"Comparison of the metabolic syndrome risk in valproate-treated patients with epilepsy and the general population in Estonia","volume":"9","author":"Rakitin","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107296_bb0175","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.yebeh.2006.02.008","article-title":"Insulin-related metabolic changes during treatment with valproate in patients with epilepsy","volume":"8","author":"Pylv\u00e4nen","year":"2006","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107296_bb0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0404.1984.tb00804.x","article-title":"Weight gain during treatment with valproate","volume":"70","author":"Dinesen","year":"1984","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"10.1016\/j.yebeh.2020.107296_bb0185","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ana.410390506","article-title":"Obesity and endocrine disorders in women taking valproate for epilepsy","volume":"39","author":"Isoj\u00e4rvi","year":"1996","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.yebeh.2020.107296_bb0190","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/088307389901400802","article-title":"Risk of excessive weight gain in epileptic children treated with valproate","volume":"14","author":"Novak","year":"1999","journal-title":"J Child Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107296_bb0195","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1212\/WNL.56.2.172","article-title":"Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy","volume":"56","author":"Biton","year":"2001","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.yebeh.2020.107296_bb0200","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1528-1157.2002.31501.x","article-title":"Serum insulin and leptin levels in valproate-associated obesity","volume":"43","author":"Pylv\u00e4nen","year":"2002","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107296_bb0205","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejpn.2008.05.005","article-title":"States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain","volume":"13","author":"Hamed","year":"2009","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107296_bb0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/08830738030180021701","article-title":"Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial","volume":"18","author":"Biton","year":"2003","journal-title":"J Child Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107296_bb0215","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1528-1167.2007.01460.x","article-title":"Adiponectin and visfatin concentrations in children treated with valproic acid","volume":"49","author":"Rauchenzauner","year":"2008","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107296_bb0220","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.yebeh.2004.11.013","article-title":"Serum lipid levels during carbamazepine therapy in epileptic children","volume":"6","author":"Mahmoudian","year":"2005","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107296_bb0225","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.eplepsyres.2009.04.005","article-title":"The effect of carbamazepine treatment on serum leptin levels","volume":"86","author":"Uludag","year":"2009","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107296_bb0230","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pediatrneurol.2008.10.003","article-title":"Effect of carbamazepine therapy on serum lipids in children with partial epilepsy","volume":"40","author":"Aggarwal","year":"2009","journal-title":"Pediatr Neurol"},{"issue":"2\u20133","key":"10.1016\/j.yebeh.2020.107296_bb0235","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eplepsyres.2007.03.010","article-title":"Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy","volume":"74","author":"Hamed","year":"2007","journal-title":"Epilepsy Res"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107296_bb0240","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00002826-199106000-00009","article-title":"Weight gain, increased appetite, and excessive food intake induced by carbamazepine","volume":"14","author":"Lampl","year":"1991","journal-title":"Clin Neuropharmacol"},{"issue":"2\u20133","key":"10.1016\/j.yebeh.2020.107296_bb0245","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.eplepsyres.2003.08.009","article-title":"Levetiracetam does not alter body weight: analysis of randomized, controlled clinical trials","volume":"56","author":"Gidal","year":"2003","journal-title":"Epilepsy Res"},{"issue":"9","key":"10.1016\/j.yebeh.2020.107296_bb0250","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.seizure.2014.05.011","article-title":"The effects of antiepileptic drugs on vascular risk factors: a narrative review","volume":"23","author":"Katsiki","year":"2014","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.yebeh.2020.107296_bb0255","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00415-002-0731-3","article-title":"Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women","volume":"249","author":"Luef","year":"2002","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2020.107296_bb0260","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1528-1157.1994.tb01792.x","article-title":"Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine","volume":"35","author":"Isoj\u00e4rvi","year":"1994","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107296_bb0265","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/088307380001500217","article-title":"Oxcarbazepine versus carbamazepine treatment and induction of serum lipid abnormalities","volume":"15","author":"Papacostas","year":"2000","journal-title":"J Child Neurol"},{"issue":"12","key":"10.1016\/j.yebeh.2020.107296_bb0270","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1468-1331.2006.01535.x","article-title":"Preliminary report on effects of oxcarbazepine-treatment on serum lipid levels in children","volume":"13","author":"Franzoni","year":"2006","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107296_bb0275","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.braindev.2011.05.009","article-title":"Effects of oxcarbazepine treatment on serum lipids and carotid intima media thickness in children","volume":"34","author":"Yi\u015f","year":"2012","journal-title":"Brain Dev"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107296_bb0280","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/ene.12262","article-title":"Lipid profile and thyroid hormone concentrations in children with epilepsy treated with oxcarbazepine monotherapy: a prospective long-term study","volume":"21","author":"Garoufi","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2020.107296_bb0285","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0404.2010.01372.x","article-title":"Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine","volume":"190","author":"Svalheim","year":"2010","journal-title":"Acta Neurol Scand Suppl"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107296_bb0290","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.410430406","article-title":"Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy","volume":"43","author":"Isoj\u00e4rvi","year":"1998","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.yebeh.2020.107296_bb0295","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/jnnp-2012-303688","article-title":"Weight change associated with antiepileptic drugs","volume":"84","author":"Pickrell","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2020.107296_bb0300","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.eplepsyres.2016.03.004","article-title":"Weight gain in children on oxcarbazepine monotherapy","volume":"122","author":"Garoufi","year":"2016","journal-title":"Epilepsy Res"},{"issue":"5","key":"10.1016\/j.yebeh.2020.107296_bb0305","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1515\/JPEM.2005.18.5.423","article-title":"Endocrine and metabolic changes in epileptic patients receiving valproic acid","volume":"18","author":"Verrotti","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"Suppl. 9","key":"10.1016\/j.yebeh.2020.107296_bb0310","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1528-1167.2007.01400.x","article-title":"The interaction between sleep and epilepsy","volume":"48","author":"Malow","year":"2007","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.yebeh.2020.107296_bb0315","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.smrv.2011.01.002","article-title":"Sleep disturbances in people with epilepsy; prevalence, impact and treatment","volume":"15","author":"Van Golde","year":"2011","journal-title":"Sleep Med Rev"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107296_bb0320","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1071-9091(96)80026-X","article-title":"The relationship between sleep and epilepsy in children","volume":"3","author":"Bourgeois","year":"1996","journal-title":"Semin Pediatr Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107296_bb0325","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s11325-011-0573-2","article-title":"Obstructive sleep apnea in epilepsy: a preliminary Egyptian study","volume":"16","author":"Shaheen","year":"2012","journal-title":"Sleep Breath"},{"issue":"6","key":"10.1016\/j.yebeh.2020.107296_bb0330","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1528-1157.2003.55702.x","article-title":"Obstructive sleep apnea in a clinical series of adult epilepsy patients: frequency and features of the comorbidity","volume":"44","author":"Manni","year":"2003","journal-title":"Epilepsia."},{"issue":"7","key":"10.1016\/j.yebeh.2020.107296_bb0335","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1212\/WNL.55.7.1002","article-title":"Obstructive sleep apnea is common in medically refractory epilepsy patients","volume":"55","author":"Malow","year":"2000","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.yebeh.2020.107296_bb0340","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.5665\/sleep.2204","article-title":"A randomized, double-blind, placebo-controlled study of an oral, extended-release formulation of phentermine\/topiramate for the treatment of obstructive sleep apnea in obese adults","volume":"35","author":"Winslow","year":"2012","journal-title":"Sleep"},{"issue":"16","key":"10.1016\/j.yebeh.2020.107296_bb0345","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1212\/WNL.0b013e318250d7bf","article-title":"Pearls & oysters: treatment of central sleep apnea with topiramate","volume":"78","author":"Westwood","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107296_bb0350","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ncl.2012.08.006","article-title":"Sleep and epilepsy: opportunities for diagnosis and treatment","volume":"30","author":"Vaughn","year":"2012","journal-title":"Neurol Clin"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107296_bb0355","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0030-6665(05)70132-8","article-title":"Recognition and consequences of obstructive sleep apnea hypopnea syndrome","volume":"32","author":"Redline","year":"1999","journal-title":"Otolaryngol Clin North Am"},{"issue":"6","key":"10.1016\/j.yebeh.2020.107296_bb0360","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/sleep\/13.6.502","article-title":"Comparison of sleep-disordered breathing among healthy elderly in the seventh, eighth, and ninth decades of life","volume":"13","author":"Hoch","year":"1990","journal-title":"Sleep"},{"issue":"9","key":"10.1016\/j.yebeh.2020.107296_bb0365","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/thorax.55.9.736","article-title":"Case\u2013control study of 24-hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects","volume":"55","author":"Davies","year":"2000","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.yebeh.2020.107296_bb0370","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1164\/ajrccm.165.5.2103001","article-title":"Obstructive sleep apnea is independently associated with insulin resistance","volume":"165","author":"Ip","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107296_bb0375","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1378\/chest.118.3.580","article-title":"Serum leptin and vascular risk factors in obstructive sleep apnea","volume":"118","author":"Ip","year":"2000","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107296_bb0380","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1034\/j.1399-3003.2000.16a23.x","article-title":"Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome","volume":"16","author":"Kiely","year":"2000","journal-title":"Eur Respir J"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020304753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020304753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:33:05Z","timestamp":1761503585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020304753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":76,"alternative-id":["S1525505020304753"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107296","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic syndrome and obstructive sleep apnea syndrome among patients with epilepsy on monotherapy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107296"}}